Jianxing He
Clinical trials sponsored by Jianxing He, explained in plain language.
-
Could removing the main tumor boost targeted therapy in advanced lung cancer?
Disease control Not yet recruitingThis study looks at whether surgically removing the primary lung tumor before starting the targeted drug osimertinib can help people with advanced EGFR-mutant non-small cell lung cancer live longer without the disease getting worse. About 118 adults with stage III-IV cancer who h…
Phase: PHASE2 • Sponsor: Jianxing He • Aim: Disease control
Last updated May 17, 2026 03:19 UTC
-
Surgery plus immunotherapy: new hope for advanced lung cancer?
Disease control Not yet recruitingThis study looks at whether removing the main lung tumor before giving immunotherapy (sintilimab) and chemotherapy can help people with advanced non-small cell lung cancer live longer without the disease getting worse. About 118 adults aged 18-75 with a specific type of lung canc…
Phase: PHASE2 • Sponsor: Jianxing He • Aim: Disease control
Last updated May 17, 2026 03:09 UTC
-
Could tubeless anesthesia make kidney transplants safer and speed up recovery?
Disease control Not yet recruitingThis study compares a new tubeless anesthesia method to standard breathing-tube anesthesia for kidney transplant patients. Researchers want to see if the tubeless approach uses fewer drugs and helps patients recover faster. Sixty adults receiving their first kidney transplant wil…
Phase: NA • Sponsor: Jianxing He • Aim: Disease control
Last updated May 15, 2026 11:54 UTC